First Efficacy Results of Capecitabine with Anthracycline- and Taxane-Based Adjuvant Therapy in High-Risk Early Breast Cancer: A Meta-Analysis

• Yiwei Jiang ,

  Contributed equally to this work with: Yiwei Jiang, Wenjin Yin

  Affiliation Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China

  ⨯
• Wenjin Yin ,

  Contributed equally to this work with: Yiwei Jiang, Wenjin Yin

  Affiliation Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China

  ⨯
• Liheng Zhou,

  Affiliation Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China

  ⨯
• Tingting Yan,

  Affiliation Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China

  ⨯
• Qiong Zhou,

  Affiliation Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China

  ⨯
• Yueyao Du,

  Affiliation Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, People's Republic of China

  ⨯
• Zhenzhou Shen,

  Affiliation Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China

  ⨯
• Zhimin Shao,

  Affiliation Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China

  ⨯
• Jinsong Lu

  * E-mail: lujjss@yahoo.com.cn

  Affiliation Department of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China

  ⨯